GSA Capital Partners’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,226
Closed -$92K 1705
2025
Q4
$92K Sell
11,226
-16,883
-60% -$152K 0.01% 1538
2025
Q3
$249K Sell
28,109
-13,348
-32% -$84.4K 0.02% 1307
2025
Q2
$217K Buy
+41,457
New +$211K 0.02% 1467
2023
Q4
Sell
-140,189
Closed -$167K 1495
2023
Q3
$167K Sell
140,189
-245,321
-64% -$380K 0.01% 1315
2023
Q2
$652K Sell
385,510
-113,548
-23% -$142K 0.07% 573
2023
Q1
$519K Buy
499,058
+9,198
+2% +$10.9K 0.05% 687
2022
Q4
$382K Buy
489,860
+250,645
+105% +$262K 0.05% 778
2022
Q3
$359K Buy
239,215
+52,954
+28% +$109K 0.05% 814
2022
Q2
$421K Buy
+186,261
New +$540K 0.06% 604

Other funds holding AVAH

GSA Capital Partners's AVAH Position: Q1 2026 in Review

GSA Capital Partners sold out of Aveanna Healthcare (AVAH) in Q1 2026, closing a stake of 11,226 shares — an estimated $92K sold.

GSA Capital Partners first reported a position in AVAH in Q2 2022 and held it in 9 quarters. The position peaked at $652K in Q2 2023. 199 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • GSA Capital Partners reported no remaining Aveanna Healthcare position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 11,226 Aveanna Healthcare shares in Q1 2026, an estimated $92K.
  • GSA Capital Partners first reported a position in Aveanna Healthcare in Q2 2022 and held it in 9 quarters.
  • GSA Capital Partners's Aveanna Healthcare position peaked at $652K in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.